Pharmaco-economic inequalities in access to antifibrotic treatment for interstitial lung disease in the Asia-pacific region

Antifibrotic drugs, available for the best part of the last decade in many parts of the world, have improved outcomes in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis. However, it is unclear whether patients suffering from these devastating conditions have timely and...

Full description

Saved in:
Bibliographic Details
Main Authors: Felix Chua, Larry Ellee Nyanti, Shirin Hui Tan, Syazatul Syakirin Sirol Aflah, Sze Shyang Kho, Gin Tsen Chai, Amornpun Wangkarnjana, Su-Ying Low, Sita Andarini, Lutz Beckert, Celeste May Campomanes, Florence KP Chan, Sally De Boer, Supparerk Disayabutr, Dina Diaz, Fanny Fachrucha, Nicole Goh, Tomohiro Handa, Adelle Jee, Kamon Kawkitinarong, Hsin-Kuo Ko, Valencia Lim, John Mackintosh, Noorul Afidza Muhammad, Moo Suk Park, Eric Tenda, Ying-Ming Tsai, Catherine Joy Tubig, Le Thuong Vu, Trang Vu, Margaret Wilsher, Wing-Ho Yip, Yoshizaku Inoue, Jin Woo Song
Format: Article
Language:en
Published: National Library of Medicine 2025
Subjects:
Online Access:https://eprints.ums.edu.my/id/eprint/45515/1/FULLTEXT.pdf
https://eprints.ums.edu.my/id/eprint/45515/
https://doi.org/10.4046/trd.2025.0056
Tags: Add Tag
No Tags, Be the first to tag this record!